UBS Group Issues Positive Forecast for Celsius (NASDAQ:CELH) Stock Price

Key Points

• UBS Group raised its price target for Celsius stock from $57.00 to $64.00, indicating a potential upside of 23.60% from the previous close.
• Institutional interest in Celsius is increasing, with 60.95% of the stock owned by institutional investors, including significant boosts from firms like Triumph Capital Management.
• The company reported a strong quarterly performance, with earnings per share of $0.47, surpassing estimates and showcasing an 83.9% year-over-year revenue growth.

Celsius (NASDAQ:CELH - Get Free Report) had its target price hoisted by stock analysts at UBS Group from $57.00 to $64.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. UBS Group's price target indicates a potential upside of 16.96% from the company's previous close.

A number of other equities analysts have also weighed in on the stock. TD Cowen upgraded shares of Celsius from a "hold" rating to a "buy" rating and lifted their price target for the company from $37.00 to $55.00 in a report on Monday, June 16th. Citigroup began coverage on Celsius in a research report on Wednesday, July 23rd. They issued a "buy" rating and a $55.00 target price on the stock. Wall Street Zen raised Celsius from a "sell" rating to a "hold" rating in a research report on Sunday, July 13th. JPMorgan Chase & Co. increased their target price on Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a research report on Thursday, July 31st. Finally, Needham & Company LLC increased their target price on Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $52.28.

Celsius Price Performance

CELH stock traded up $0.72 on Friday, reaching $54.72. The company had a trading volume of 10,569,151 shares, compared to its average volume of 8,305,835. Celsius has a 1 year low of $21.10 and a 1 year high of $55.87. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The company's fifty day moving average is $44.83 and its 200 day moving average is $36.40. The company has a market cap of $14.10 billion, a P/E ratio of 147.89, a PEG ratio of 1.80 and a beta of 1.40.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The firm had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. During the same quarter in the prior year, the company earned $0.28 EPS. Celsius's revenue was up 83.9% on a year-over-year basis. On average, research analysts forecast that Celsius will post 0.89 earnings per share for the current year.

Insider Activity

In other news, major shareholder William H. Milmoe sold 300,000 shares of Celsius stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total transaction of $14,181,000.00. Following the sale, the insider directly owned 18,017,770 shares of the company's stock, valued at approximately $851,699,987.90. The trade was a 1.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jarrod Langhans sold 5,000 shares of the business's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $51.18, for a total value of $255,900.00. Following the completion of the transaction, the chief financial officer owned 109,227 shares in the company, valued at approximately $5,590,237.86. This trade represents a 4.38% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,111,141 shares of company stock worth $52,241,605. 2.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CELH. Alliancebernstein L.P. grew its stake in Celsius by 26.3% in the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock worth $642,769,000 after purchasing an additional 3,753,055 shares in the last quarter. Champlain Investment Partners LLC acquired a new position in Celsius in the fourth quarter worth about $85,068,000. Alyeska Investment Group L.P. grew its stake in Celsius by 60.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after purchasing an additional 2,591,345 shares in the last quarter. FMR LLC grew its stake in Celsius by 64.2% in the fourth quarter. FMR LLC now owns 4,055,148 shares of the company's stock worth $106,813,000 after purchasing an additional 1,585,839 shares in the last quarter. Finally, AQR Capital Management LLC acquired a new position in Celsius in the first quarter worth about $39,412,000. Institutional investors and hedge funds own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.